Review

[Biomedicine & Pharmacotherapy] The authors in-depth review of the advancement of Lipocalin 2 (LCN2) in the context of breast cancer occurrence and development.

[NPJ Genomic Medicine] Investigators provide a forward-looking perspective on the field of RNA medical products and the potential long-term innovations and policy shifts enabled by this revolutionary and game-changing technological platform.

[Journal of Advanced Research] Investigators summarize the latest published research on resveratrol’s effect in the prevention of CRC, its regulatory actions, specifically on the p53 pathway, and its treatment options.

[Journal of Comparative Neurology] The authors review the ability of ARHGAP11B to amplify basal progenitors and to expand a primate neocortex and discuss the contribution of ARHGAP11B to neocortex expansion during human evolution.

[Nature Reviews Clinical Oncology] The authors discuss the interplay between myeloid-derived suppressor cells (MDSCs) and various other cell types found in tumors as well as the mechanisms by which MDSCs promote tumor progression.

[Expert Opinion On Therapeutic Targets] The authors review the role of different molecular determinants of prostate cancer progression to lethal disease including the phenotypic dynamic of cell plasticity, EMT-MET interconversion, and signaling-pathways driving prostate cancer cells to advance and metastasize.